• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 3. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 4. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 5. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Phenylpiperidines

Recent Advances in the Study of 5-(Piperidin-4-yl)-1H-indole (CAS: 383861-22-1) in Chemical Biology and Pharmaceutical Research

The compound 5-(Piperidin-4-yl)-1H-indole (CAS: 383861-22-1) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile pharmacological properties and potential therapeutic applications. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, biological activities, and potential as a drug candidate. The information presented here is based on a comprehensive review of recent academic publications, patents, and industry reports.

Recent studies have highlighted the role of 5-(Piperidin-4-yl)-1H-indole as a key scaffold in the development of novel kinase inhibitors. Its structural features, including the piperidine ring and indole moiety, make it an attractive candidate for modulating various signaling pathways. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy in inhibiting specific tyrosine kinases implicated in cancer progression. The compound's ability to bind to the ATP-binding site of these kinases was confirmed through X-ray crystallography and molecular docking studies.

In addition to its kinase inhibitory properties, 5-(Piperidin-4-yl)-1H-indole has shown promise in the treatment of neurological disorders. A recent preclinical study reported its neuroprotective effects in models of Parkinson's disease, attributed to its ability to cross the blood-brain barrier and modulate dopaminergic signaling. The compound's pharmacokinetic profile, including its metabolic stability and oral bioavailability, was also evaluated, suggesting its potential for further development as a CNS-active agent.

The synthesis of 5-(Piperidin-4-yl)-1H-indole and its derivatives has been a focal point of recent research. A 2024 patent application disclosed a novel, high-yield synthetic route that improves upon traditional methods, reducing the number of steps and minimizing the use of hazardous reagents. This advancement is expected to facilitate large-scale production and further exploration of the compound's therapeutic potential. Additionally, computational studies have been employed to design analogs with enhanced selectivity and potency, paving the way for next-generation drug candidates.

Despite these promising findings, challenges remain in the development of 5-(Piperidin-4-yl)-1H-indole-based therapeutics. Issues such as off-target effects and potential toxicity need to be addressed through rigorous preclinical testing. However, the compound's unique pharmacological profile and the growing body of research supporting its applications underscore its significance in the field. Future studies are expected to explore its utility in combination therapies and its potential in other disease areas, such as inflammation and infectious diseases.

In conclusion, 5-(Piperidin-4-yl)-1H-indole (CAS: 383861-22-1) represents a promising scaffold for drug discovery, with demonstrated efficacy in kinase inhibition and neuroprotection. Continued research into its mechanisms of action, synthetic optimization, and therapeutic applications will be critical in translating these findings into clinical benefits. This brief serves as a timely update for researchers and industry professionals engaged in the development of novel chemical entities for biomedical applications.

• 81887-48-1((R)-4-(3-Piperidinyl)-1H-indole)
• 103827-82-3(4-(piperidin-4-yl)-1H-indole)
• 87584-71-2(4-[(3S)-piperidin-3-yl]-1H-indole)
• 885273-33-6(1H-Indole,5-(1-methyl-4-piperidinyl)-)
• 81887-47-0(4-piperidin-3-yl-1h-indole)
• 16176-75-3(4-(piperidin-3-yl)-1H-indole)
• 914223-10-2(6-(piperidin-4-yl)-1H-indole)
• 321745-84-0(6-(1-METHYL-PIPERIDIN-4-YL)-1H-INDOLE)
• 1020277-40-0(6-(piperidin-4-yl)quinoline)
• 1260814-13-8(7-(piperidin-4-yl)quinoline)